US 2014/0228426 A1Published application

Amorphous cabazitaxel

AssigneeYung Shin Pharm. Ind. Co., Ltd.

InventorsLiang-Rern Kung, Yi-Ting HUNG, Tung-Shen FANG, Po-Wei CHANG, Tsang-Miao HUANG

Life of this patent

Estimating the term…

Abstract

The present invention is directed to an amorphous form of cabazitaxel, which can be prepared by dissolving a solid form of cabazitaxel in an organic solvent, and removing the organic solvent to dryness. The amorphous form of cabazitaxel is characterized by DSC as in FIG. 1 and/or X-ray powder diffraction pattern as in FIG. 2.

Claims11

Dependent claims

An amorphous form of cabazitaxel characterized by DSC as in FIG. 1 and/or X-ray powder diffraction pattern as in FIG. 2.

Dependencies are inferred from the claim text.

Facts

Application: 13/952,117Filed 26 Jul 2013
Priority: 31 Jul 2012
Published: 14 Aug 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

C07D 305/14
Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms: condensed with carbocyclic rings or…
A61K 31/337
Having oxygen as the only ring hetero atom, e.g. fungichromin: having four-membered rings, e.g. taxol
A61P 35/00
Antineoplastic agents
C07D
Heterocyclic compounds

Family

Application61/677,991Us provisional application · filed 31 Jul 2012
US 9,012,665 B2Related patent
US 2014/0228426 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results